These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25951663)

  • 1. The role of CYP2C9 genetic polymorphisms in the oxidative metabolism of diclofenac in vitro.
    Xia MM; Wang L; PAan PP; Wang HY; Chen MC; Chen Y; Dai DP; Cai JP; Hu GX
    Pharmazie; 2014 Dec; 69(12):898-903. PubMed ID: 25951663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cytochrome P450 2C9 polymorphism on bosentan metabolism.
    Chen M; Zhang Y; Pan P; Wang L; Zhan Y; Jin H; Xia M; Wang X; Dai D; Cai J; Hu G
    Drug Metab Dispos; 2014 Nov; 42(11):1820-5. PubMed ID: 25142737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro.
    Wang L; Bao SH; Pan PP; Xia MM; Chen MC; Liang BQ; Dai DP; Cai JP; Hu GX
    Drug Dev Ind Pharm; 2015; 41(8):1363-7. PubMed ID: 25144335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects.
    Maekawa K; Harakawa N; Sugiyama E; Tohkin M; Kim SR; Kaniwa N; Katori N; Hasegawa R; Yasuda K; Kamide K; Miyata T; Saito Y; Sawada J
    Drug Metab Dispos; 2009 Sep; 37(9):1895-903. PubMed ID: 19541829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.
    Tang PF; Zheng X; Hu XX; Yang CC; Chen Z; Qian JC; Cai JP; Hu GX
    Drug Des Devel Ther; 2020; 14():5129-5141. PubMed ID: 33262574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolism of phenytoin in 36 CYP2C9 variants found in the Chinese population.
    Chen LG; Wang Z; Zhu Y; Xiong JH; Sun LR; Dai DP; Cai JP; Hu GX
    Chem Biol Interact; 2016 Jun; 253():93-9. PubMed ID: 27163851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CYP2C9 polymorphism in losartan oxidation.
    Yasar U ; Tybring G; Hidestrand M; Oscarson M; Ingelman-Sundberg M; Dahl ML; Eliasson E
    Drug Metab Dispos; 2001 Jul; 29(7):1051-6. PubMed ID: 11408373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CYP2C9*3 and CYP2C9*13 on Diclofenac Metabolism and Inhibition-based Drug-Drug Interactions.
    Zi J; Liu D; Ma P; Huang H; Zhu J; Wei D; Yang J; Chen C
    Drug Metab Pharmacokinet; 2010; 25(4):343-50. PubMed ID: 20814155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain.
    Llerena A; Alvarez M; Dorado P; González I; Peñas-LLedó E; Pérez B; Cobaleda J; Calzadilla LR
    Pharmacogenomics J; 2014 Jun; 14(3):229-34. PubMed ID: 23959274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59.
    Dai DP; Wang SH; Li CB; Geng PW; Cai J; Wang H; Hu GX; Cai JP
    Drug Metab Dispos; 2015 Aug; 43(8):1246-9. PubMed ID: 25994031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans.
    Kirchheiner J; Meineke I; Steinbach N; Meisel C; Roots I; Brockmöller J
    Br J Clin Pharmacol; 2003 Jan; 55(1):51-61. PubMed ID: 12534640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CYP2C9 genetic polymorphism in carvedilol O-desmethylation in vitro.
    Pan PP; Weng QH; Zhou CJ; Wei YL; Wang L; Dai DP; Cai JP; Hu GX
    Eur J Drug Metab Pharmacokinet; 2016 Feb; 41(1):79-86. PubMed ID: 25476996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62.
    Chen H; Dai DP; Zhou S; Liu J; Wang SH; Wu HL; Zhou Q; Geng PW; Chong J; Lü Y; Cai JP; Yang JF
    Chem Biol Interact; 2020 Aug; 327():109168. PubMed ID: 32531309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9*3 allele.
    Shimamoto J; Ieiri I; Urae A; Kimura M; Irie S; Kubota T; Chiba K; Ishizaki T; Otsubo K; Higuchi S
    Eur J Clin Pharmacol; 2000 Apr; 56(1):65-8. PubMed ID: 10853880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ethanol on S-warfarin and diclofenac metabolism by recombinant human CYP2C9.1.
    Tatsumi A; Ikegami Y; Morii R; Sugiyama M; Kadobayashi M; Iwakawa S
    Biol Pharm Bull; 2009 Mar; 32(3):517-9. PubMed ID: 19252308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in lornoxicam 5'-hydroxylation.
    Iida I; Miyata A; Arai M; Hirota M; Akimoto M; Higuchi S; Kobayashi K; Chiba K
    Drug Metab Dispos; 2004 Jan; 32(1):7-9. PubMed ID: 14709614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 36 CYP2C9 variants found in the Chinese population on losartan metabolism in vitro.
    Wang YH; Pan PP; Dai DP; Wang SH; Geng PW; Cai JP; Hu GX
    Xenobiotica; 2014 Mar; 44(3):270-5. PubMed ID: 23844998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of CYP2C9 polymorphism found in the Chinese population on the metabolism of propofol in vitro.
    Lian QQ; Pan PP; Li JW; Lin H; Hu GX; Zuo MZ; Cai JP
    Biol Pharm Bull; 2015; 38(4):531-5. PubMed ID: 25832633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants.
    Patton AL; Seely KA; Yarbrough AL; Fantegrossi W; James LP; McCain KR; Fujiwara R; Prather PL; Moran JH; Radominska-Pandya A
    Biochem Biophys Res Commun; 2018 Apr; 498(3):597-602. PubMed ID: 29522717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic activity on valsartan of 38 CYP2C9 variants from the Chinese population.
    Yuan LJ; Qian JC; Li XY; Cui J; Cai JP; Hu GX
    Chem Biol Interact; 2022 Feb; 353():109799. PubMed ID: 34998819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.